According to FutureWise analysis the market for GI stool testing in 2023 is US$ 1.03 billion, and is expected to reach US$ 1.6 billion by 2031 at a CAGR of 7.1%.
The analysis of faeces or stool samples to diagnose intestinal infections or diseases is known as GI stool testing. Bowel inflammation, malabsorption, and cancer are all examples of GI disorders. The growing prevalence of GI diseases due to junk food consumption, hectic lifestyles, and an ageing population is driving growth in the GI stool testing market. This population is conditioned to gastrointestinal infections. Furthermore, both the public and private sectors are expected to increase their investments in the healthcare sector, which is expected to drive market growth.
The vast majority of studies show a connection between gut health and overall health. The impacts of nutrition and other factors on health, including digestive, immunological, metabolic, and neuroendocrine processes, are mediated by the gut microbiota in particular. Using the right methods to assess GI health can assist practitioners in identifying the underlying causes of chronic illness. For instance, SDNA tests, commonly referred to as FIT-DNA tests, look for traces of DNA (genetic material) secreted by polyps and/or colon cancers rather than hiding the blood. The most popular stool test for this kind of screening is Cologuard. The Cologuard test can identify blood in a stool sample and ten other factors linked to colon cancer.
Recent developments by key players in GI stool testing Market:
In June 2022, Prenetics Group Limited, a global leader in genomic and diagnostic testing, launched ColoClear by Circle (ColoClear), a novel, non-invasive, at-home screening test for detecting early signs of colorectal cancer in Hong Kong.
The prevalence of colorectal cancer is rising globally, which is anticipated to fuel market expansion over the forecast period. Additionally, a few of the factors fuelling the market expansion are the growing senior population, who are particularly susceptible to GI infections, and the rising prevalence of GI health conditions brought on by increased fast food consumption, stress, and hectic lives. Materials called reagents are often used in testing and analysis. The high mortality rate among patients with numerous co-morbidities and the overcrowding of intensive care units were the two main factors that worsened the effects of the disease and ultimately increased the strain on healthcare systems, according to an article published in 2021 with the title "Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence." Patients with inflammatory bowel disease (IBD), who are more likely to contract opportunistic infections as a result of their immunosuppressive-based treatments, have drawn particular attention from the gastroenterology community. Therefore, considering the aforementioned circumstances, COVID-19 had a major impact on the target market. The GI stool testing market is expected to be dominated by reagents as diagnostic technology develops. Chemiluminescent assays are used to assist in the diagnosis of gastrointestinal illnesses. The use of enzyme-labelled antibodies for detection is recognised to offer a precise diagnosis. Also, increasing R&D expenditure in the field of GI stool testing will present profitable prospects to market players.
FutureWise Market Research has published a report that provides an insightful analysis of GI stool testing kit market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the GI stool testing kit market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.